MEND SELECTED AS A TECHNOLOGY PIONEER BY THE WORLD ECONOMIC FORUM. Read more
MEND applies emerging and advanced delivery and manufacturing technologies to drug and vaccine candidates for diseases of poverty.
These technologies often make the difference between a drug or vaccine that cannot practically be developed because of problems like instability or high costs and one that succesfully meets the restrictive criteria - low cost manufacturing, oral or needle-free dosing, lack of refrigeration - necessary to help patients in countries where the need is greatest.
We believe that the best solutions to the global challenge come from broad and transparent collaboration amongst very diverse groups, including the substantial inclusion of emerging research and capabilities in the developing world.Learn More